NCT06936800View on ClinicalTrials.gov

Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP)

NAEnrolling by invitationINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Chronic PancreatitisPancreatic Duct Stones
Interventions
DRUG

Pinaverium bromide

Preoperative, intraoperative, and postoperative oral administration of 100mg povidonium bromide in P-ESWL

DRUG

Placebo for control group

Preoperative, intraoperative, and postoperative oral placebo 100mg for P-ESWL

Trial Locations (1)

107

Department of Gastroenterology, Qilu hospital of Shandong University, Jinan

All Listed Sponsors
lead

Yanqing Li

OTHER